Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.48B | 7.85B | 6.63B | 5.86B | 4.74B | 4.61B |
Gross Profit | 2.42B | 3.02B | 2.68B | 2.30B | 1.97B | 2.01B |
EBITDA | 2.98B | 2.73B | 2.40B | 2.01B | 1.70B | 1.52B |
Net Income | 1.08B | 951.68M | 340.09M | 141.21M | 162.04M | -41.52M |
Balance Sheet | ||||||
Total Assets | 53.29B | 51.04B | 44.01B | 37.89B | 34.91B | 32.48B |
Cash, Cash Equivalents and Short-Term Investments | 3.50B | 3.51B | 1.99B | 631.68M | 269.26M | 1.55B |
Total Debt | 2.50B | 16.76B | 16.12B | 14.96B | 14.68B | 14.22B |
Total Liabilities | 18.71B | 18.47B | 17.64B | 16.50B | 15.91B | 15.26B |
Stockholders Equity | 33.96B | 31.96B | 25.40B | 20.29B | 17.64B | 15.97B |
Cash Flow | ||||||
Free Cash Flow | 2.24B | 2.20B | 1.55B | 1.30B | 1.26B | 1.35B |
Operating Cash Flow | 2.45B | 2.26B | 1.60B | 1.33B | 1.28B | 1.36B |
Investing Cash Flow | -6.96B | -5.51B | -5.71B | -3.70B | -4.52B | 2.35B |
Financing Cash Flow | 5.63B | 4.91B | 5.45B | 2.76B | 1.57B | -2.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $99.87B | 164.64 | 3.52% | 1.75% | 23.31% | 36.07% | |
78 Outperform | $5.87B | 33.39 | 7.02% | 4.36% | 43.27% | 80.97% | |
75 Outperform | $10.61B | 22.98 | 10.53% | 7.31% | 10.56% | 45.37% | |
68 Neutral | $13.18B | 46.72 | 3.26% | 6.61% | 23.65% | 12.82% | |
68 Neutral | $85.67B | 191.29 | 1.36% | 2.96% | 10.00% | ― | |
59 Neutral | C$1.26B | -0.04 | -8.19% | 4.99% | 10.83% | -22.67% | |
59 Neutral | $5.66B | ― | -6.83% | 7.70% | -7.26% | 18.45% |
On June 27, 2025, Welltower OP LLC issued $1.25 billion in notes, comprising $600 million of 4.500% Notes due 2030 and $650 million of 5.125% Notes due 2035. The proceeds from these notes are intended for general corporate purposes, including debt repayment and investment in healthcare and seniors housing properties, reflecting the company’s strategic focus on expanding its real estate portfolio in these sectors.
The most recent analyst rating on (WELL) stock is a Buy with a $155.00 price target. To see the full list of analyst forecasts on Welltower stock, see the WELL Stock Forecast page.
At the 2025 Annual Meeting of Shareholders on May 22, 2025, Welltower Inc. shareholders elected nine directors, ratified Ernst & Young LLP as the independent auditor for 2025, approved executive compensation, and amended the 2022 Long-Term Incentive Plan. These decisions reflect shareholder support for the company’s leadership and strategic direction, potentially strengthening its governance and financial oversight.
The most recent analyst rating on (WELL) stock is a Buy with a $155.00 price target. To see the full list of analyst forecasts on Welltower stock, see the WELL Stock Forecast page.